Literature DB >> 17668936

Irreversible electroporation: implications for prostate ablation.

Gary Onik1, Paul Mikus, Boris Rubinsky.   

Abstract

Percutaneous prostate cryo-ablation has become an accepted treatment for primary prostate cancer. Thermal tissue ablation based on cold, however, does have some distinct limitations. These include, variable damage at the cryo lesions margin, injury to adjacent structures such as rectum, urethra and NVB (neurovascular bundle), and long procedure time due to the need for multiple freeze thaw cycles, that have limited the acceptance of this modality. Irreversible electroporation IRE, is a new non-thermal ablation modality that uses short pulses of DC electric current to create irreversible pore in the cell membrane, thus, causing cell death. This method theoretically should have significant advantages in ablating prostate tissue. Six males dogs had their prostates treated using IRE. Pulses were applied using a DC generator that delivered pulses in the microsecond range of duration, with a variable pulse interval and voltage range. IRE probes were placed percutaneously or trans-rectally using trans-rectal ultrasound guidance. In one of the dogs, the lesions were made purposely to include the rectum, urethra, and neurovascular bundle (NVB). Subjects were followed for 1 to 14 days before sacrifice. IRE lesions in the prostate had unique characteristics compared to thermal lesions. The margins of the IRE lesions was very distinct with a narrow zone of transition from normal to complete necrosis, there was complete destruction within the IRE lesion, and rapid resolution of the lesions with marked shrinkage within two weeks. Structures such as urethra, vessels, nerves, and rectum were unaffected by the IRE application. IRE lesions have characteristics that are distinctly different than thermal lesions. The differences could be very advantageous in a clinical setting, improving the results and acceptance of prostate ablation.

Entities:  

Mesh:

Year:  2007        PMID: 17668936     DOI: 10.1177/153303460700600405

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  99 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue.

Authors:  Mohammad Hjouj; Boris Rubinsky
Journal:  J Membr Biol       Date:  2010-07-15       Impact factor: 1.843

3.  MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.

Authors:  Yue Zhang; Yang Guo; Ann B Ragin; Robert J Lewandowski; Guang-Yu Yang; Grace M Nijm; Alan V Sahakian; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

Review 4.  Irreversible Electroporation.

Authors:  Govindarajan Narayanan
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

5.  Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.

Authors:  Henk van der Poel; Laurence Klotz; Gerald Andriole; Abdel-Rahmène Azzouzi; Anders Bjartell; Olivier Cussenot; Freddy Hamdy; Markus Graefen; Paolo Palma; Arturo Rodriguez Rivera; Christian G Stief
Journal:  World J Urol       Date:  2015-06-03       Impact factor: 4.226

Review 6.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

7.  Microscopic histological characteristics of soft tissue sarcomas: analysis of tissue features and electrical resistance.

Authors:  A L Tosi; L G Campana; F Dughiero; M Forzan; M Rastrelli; E Sieni; C R Rossi
Journal:  Med Biol Eng Comput       Date:  2016-10-01       Impact factor: 2.602

8.  A statistical model for multidimensional irreversible electroporation cell death in tissue.

Authors:  Alex Golberg; Boris Rubinsky
Journal:  Biomed Eng Online       Date:  2010-02-26       Impact factor: 2.819

9.  Recent advances in focal therapy of prostate and kidney cancer.

Authors:  Matvey Tsivian; Thomas J Polascik
Journal:  F1000 Med Rep       Date:  2010-01-18

10.  Electrical resistance of human soft tissue sarcomas: an ex vivo study on surgical specimens.

Authors:  L G Campana; M Cesari; F Dughiero; M Forzan; M Rastrelli; C R Rossi; E Sieni; A L Tosi
Journal:  Med Biol Eng Comput       Date:  2015-09-01       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.